Sarwal Rakesh, Dhamija Rajinder K, Jain Khushbu, Basavaraddi Ishwar V
Advisor, National Institution for Transforming India (NITI) Aayog, New Delhi, India.
Professor and Head, Lady Hardinge Medical College, New Delhi, India.
J Ayurveda Integr Med. 2023 Jan-Feb;14(1):100586. doi: 10.1016/j.jaim.2022.100586. Epub 2022 May 6.
The global outbreak of COVID-19 has created a challenging situation, especially for the frontline Health Care Professionals (HCPs), who are routinely exposed and thus are at a higher risk of infection. Pranayama, a component of Yoga, is known to improve immune function and reduce infection. However, no clinical trial on the efficacy of Pranayama in preventing COVID-19 has yet been conducted.
This quasi-randomized clinical trial assessed the efficacy of Pranayama in preventing COVID-19 infection in HCPs routinely exposed to COVID-19.
The study was conducted at 5 different COVID-19 hospitals, India in year 2020. The inclusion criteria were being an HCP exposed to COVID-19 patients and being negative on antibody tests. 280 HCPs were recruited sequential and assigned to intervention and control groups. Of these, 250 HCPs completed the study. The intervention was twice daily practice, for 28 days, of specially designed Pranayama modules under the online supervision of Yoga instructors. The HCPs in the control group were advised to continue their normal daily routine, but no pranayama sessions. Participants who developed symptoms suggestive of COVID-19 were subjected to Reverse Transcriptase-Polymerase Chain Reaction (RT-PCR) or Point of Care Rapid Antigen Test (RAT) for confirmation of the diagnosis. All the participants were tested for antibodies to COVID-19 on 28th day of the intervention to detect any asymptomatic infection.
The intervention (123) and control (127) groups had comparable demographics and baseline characteristics. At end of 28 days of intervention, nine participants in the control group and one in the intervention group developed COVID-19 (P-value: 0.01, Odds Ratio: 0.107, 95% CI: 0.86; Risk Ratio: 0.11, 95% CI: 0.89).
The intervention of twice daily practice of the Pranayama module for 28 days in HCPs might have made a noteworthy contribution and may have helped in preventing COVID-19 infection.
新型冠状病毒肺炎(COVID-19)的全球大流行造成了具有挑战性的局面,尤其是对于一线医护人员而言,他们经常接触病毒,因此感染风险更高。瑜伽的一个组成部分——调息法,已知可改善免疫功能并减少感染。然而,尚未进行关于调息法预防COVID-19疗效的临床试验。
本半随机临床试验评估了调息法对经常接触COVID-19的医护人员预防COVID-19感染的疗效。
该研究于2020年在印度的5家不同的COVID-19医院进行。纳入标准为身为接触COVID-19患者的医护人员且抗体检测呈阴性。连续招募了280名医护人员并将其分配至干预组和对照组。其中,250名医护人员完成了研究。干预措施为在瑜伽教练的在线监督下,每天进行两次、为期28天的专门设计的调息法练习。建议对照组的医护人员继续其正常的日常工作,但不进行调息法练习。出现COVID-19疑似症状的参与者接受逆转录聚合酶链反应(RT-PCR)或即时护理快速抗原检测(RAT)以确诊。在干预的第28天对所有参与者进行COVID-19抗体检测,以检测任何无症状感染。
干预组(123人)和对照组(127人)的人口统计学和基线特征具有可比性。在干预28天结束时,对照组有9名参与者感染了COVID-19,干预组有1名参与者感染(P值:0.01,优势比:0.107,95%置信区间:0.86;风险比:0.11,95%置信区间:0.89)。
医护人员每天进行两次、为期28天的调息法练习干预可能做出了显著贡献,并可能有助于预防COVID-19感染。